6-K

0001193125-22-263289.txt : 20221017 0001193125-22-263289.hdr.sgml : 20221017 20221017061901 ACCESSION NUMBER: 0001193125-22-263289 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 11 CONFORMED PERIOD OF REPORT: 20221017 FILED AS OF DATE: 20221017 DATE AS OF CHANGE: 20221017 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Abcam plc CENTRAL INDEX KEY: 0001492074 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 980487031 STATE OF INCORPORATION: X0 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-39633 FILM NUMBER: 221312508 BUSINESS ADDRESS: STREET 1: DISCOVERY DRIVE STREET 2: CAMBRIDGE BIOMEDICAL CAMPUS CITY: CAMBRIDGE STATE: X0 ZIP: CB2 0AX BUSINESS PHONE: 44(0)1223696000 MAIL ADDRESS: STREET 1: DISCOVERY DRIVE STREET 2: CAMBRIDGE BIOMEDICAL CAMPUS CITY: CAMBRIDGE STATE: X0 ZIP: CB2 0AX FORMER COMPANY: FORMER CONFORMED NAME: Abcam PLC DATE OF NAME CHANGE: 20100514 6-K 1 d408355d6k.htm 6-K 6-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of October 2022

Commission File Number: 001-39633

Abcam plc

(Translation of registrant’s name into English)

Discovery Drive

Cambridge Biomedical Campus

Cambridge, CB2 0AX

United Kingdom

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☒ Form 40-F ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐

INFORMATION CONTAINED IN THIS REPORT ON FORM 6-K

Intended Delisting and Cancellation of Ordinary Shares from Trading on AIM

On October 17, 2022, Abcam plc (the “Company”) issued a regulatory news service announcement (the “AIM Delisting RNS Announcement”) announcing its intention to cancel the admission to trading of the Company’s ordinary shares, nominal value £0.002 per share (the “Ordinary Shares”), on the AIM market of the London Stock Exchange (the “AIM Delisting”). The Company provided the requisite 20 business days’ notice of the intended AIM Delisting. Subject to shareholder approval, the Company intends that the last day of trading of the Ordinary Shares on AIM will be December 13, 2022, and the proposed AIM Delisting will be effective from 7:00 a.m., London time, on December 14, 2022. Following the AIM Delisting, the Company’s American Depositary Shares, each representing one Ordinary Share, will remain listed on the Nasdaq Global Select Market (“Nasdaq”) and all public trading of securities in the Company will take place solely on Nasdaq.

The AIM Delisting RNS Announcement is furnished herewith as Exhibit 99.1 to this Report on Form 6-K.

General Meeting of Shareholders

On October 17, 2022, the Company posted or made available to its shareholders on the Investors section of its website certain materials related to the AIM Delisting and the general meeting of shareholders of the Company to be held on November 11, 2022, including a shareholder circular, form of proxy and a set of frequently asked questions about the AIM Delisting (collectively, the “Shareholder Materials”).

The Shareholder Materials are furnished herewith as Exhibits 99.2, 99.3 and 99.4, respectively, to this Report on Form 6-K.

Forward-Looking Statements

This Report on Form 6-K contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Any express or implied statements contained in this Report on Form 6-K that are not statements of historical fact may be deemed to be forward-looking statements, including, without limitation, statements regarding the implications of the AIM Delisting on the trading of the Company’s equity securities and related timing, as well as statements that include the words “expect,” “intend,” “plan,” “believe,” “project,” “forecast,” “estimate,” “may,” “should,” “anticipate” and similar statements of a future or forward-looking nature. Forward-looking statements are neither promises nor guarantees, but involve known and unknown risks and uncertainties that could cause actual results to differ materially from those projected, including, without limitation: the risk that anticipated trading volume in the Company’s equity securities on Nasdaq may not materialize; and the important factors discussed under the caption “Risk Factors” in the Company’s Annual Report on Form 20-F for the year ended December 31, 2021, which is on file with the U.S. Securities and Exchange Commission (“SEC”) and is available on the SEC website at www.sec.gov, as such factors may be updated from time to time in the Company’s other filings with the SEC. Any forward-looking statements contained in this Report on Form 6-K speak only as of the date hereof and accordingly undue reliance should not be placed on such statements. Abcam disclaims any obligation or undertaking to update or revise any forward-looking statements contained in this Report on Form 6-K, whether as a result of new information, future events or otherwise, other than to the extent required by applicable law.

EXHIBIT INDEX


Exhibit No.		Description

99.1		AIM Delisting RNS Announcement

99.2		Shareholder Circular (Proposed Cancellation of Admission of Ordinary Shares to Trading on AIM and Notice of General Meeting) of Abcam plc, dated October 17, 2022

99.3		Form of Proxy

99.4		AIM Delisting Frequently Asked Questions

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.


	ABCAM PLC

Date: October 17, 2022	By:	/s/ Alan Hirzel
		Name:	Alan Hirzel
		Title:	Chief Executive Officer

EX-99.1 2 d408355dex991.htm EX-99.1 EX-99.1

Exhibit 99.1

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY IN, OR INTO OR FROM ANY JURISDICTION IN WHICH THE SAME WOULD BE A VIOLATION OF THE LAWS OF SUCH JURISDICTION. NEITHER THIS ANNOUNCEMENT, NOR ANYTHING CONTAINED HEREIN, SHALL FORM THE BASIS OF, OR BE RELIED UPON IN CONNECTION WITH, ANY OFFER OR COMMITMENT WHATSOEVER IN ANY JURISDICTION.

ABCAM PLC

Proposed Cancellation of Admission of Ordinary Shares to Trading on AIM

and

Notice of General Meeting

Notice of General Meeting to be held on 11 November 2022

17 October 2022

CAMBRIDGE, Abcam plc, AIM:ABC and Nasdaq:ABCM (“Abcam” or the ”Company”), a global leader in the supply of life science research tools, today announces:

- the Company’s intention to cancel the admission of its ordinary shares of nominal value 0.02 pence each (the “Ordinary Shares”) to trading on AIM (the “AIM Delisting”), subject to shareholder approval, with effect from 14 December 2022. Subject to shareholder approval, the Company’s last day of trading on AIM will be 13 December 2022. Abcam will retain the listing on the Nasdaq Global Select Market (“Nasdaq”) of American Depositary Shares, each representing one Ordinary Share (the “ADSs”), under ticker symbol “ABCM”, and all public trading of securities in the Company will take place on that exchange. Existing holders of ADSs not also holding Ordinary Shares do not need to take any action in relation to the AIM Delisting; and

- the posting of a circular to Abcam shareholders (the “Circular”), which contains further information on the AIM Delisting and the process to deposit Ordinary Shares for delivery of ADSs and notice of a general meeting to be held on 11 November 2022 at Discovery Drive, Cambridge Biomedical Campus, Cambridge, CB2 0AX, United Kingdom at 2.00 p.m. (London time) (the “General Meeting”) at which shareholder approval will be sought, inter alia, for the AIM Delisting.

The Proposed AIM Delisting and the General Meeting

Highlights

•

Following the AIM Delisting, the Company’s ADSs will remain listed on Nasdaq, which will become the primary trading venue for its equity securities, and all public trading of securities in the Company will take place on that exchange.

•

The board of directors of the Company (the “Board” and the “Directors”) expects that the AIM Delisting and moving to a sole listing on Nasdaq will further enhance the liquidity of trading in the Company’s securities by combining on Nasdaq the volume of transactions from both Nasdaq and AIM.

•

The Company is providing an opportunity for shareholders to deposit their Ordinary Shares with the Company’s ADS depositary in exchange for delivery of ADSs, without cost, in connection with the AIM Delisting whether prior, on, or subsequent to 14 December 2022 (being the date on which the AIM Delisting takes effect).

Alan Hirzel, Chief Executive Officer of Abcam, said:

“This proposed listing change will make it possible for Abcam to attract more investors to our global business. With the change, we see a path to creating value by increasing stock trading

liquidity for our current and potential shareholders. We are grateful to have the support from current shareholders for our proposal and look forward to attracting new life science investors to the Abcam story.”

The Company will today be posting the Circular to shareholders, which will set out further information on the process to deposit Ordinary Shares for delivery of ADSs, including personalised forms for those holders of certificated Ordinary Shares who wish to deposit their Ordinary Shares for delivery of ADSs, as well as containing the notice of General Meeting. Copies will also be available on Abcam’s website at https://corporate.abcam.com/.

Background

The Company was incorporated in 1998 and its Ordinary Shares have been admitted to trading on the AIM market of the London Stock Exchange since 2005. In October 2020, the Company completed a direct listing of ADSs representing 10,287,000 Ordinary Shares on Nasdaq. The listing of the ADSs on Nasdaq provided the Company with access to a broader US investor base, in particular from long-term life science investors, access to deeper US capital pools, and provided additional liquidity for the Company’s shareholders.

Since the listing of the ADSs on Nasdaq in October 2020, the number of Ordinary Shares, represented by ADSs, that are tradeable on Nasdaq has approximately tripled. As at 12 October 2022, being the last practicable date prior to the date of the CIrcular, approximately 14 per cent. of the Company’s Ordinary Shares are represented by ADSs tradeable on Nasdaq. While only 14 per cent. of our Ordinary Shares trade through ADSs in the US market, it represents approximately 24 per cent. of the overall average daily volume of the Ordinary Shares on both AIM and Nasdaq over the past one month to 12 October 2022.

The Company is not expecting any significant operating changes as a result of the AIM Delisting and is not proposing to alter its domicile or to relocate its global headquarters from Cambridge in the UK.

All shareholders who have not already deposited their Ordinary Shares for delivery of ADSs are currently able to do so at any time. Affiliates of the Company who deposit their ordinary shares may be subject to limitations on resale of ADSs under U.S. securities laws.

The AIM Rules for Companies require that, unless the London Stock Exchange otherwise agrees, the cancellation of a company’s shares from trading on AIM requires the consent of not less than 75 per cent. of votes cast by its shareholders voting in a general meeting. Accordingly, the Board is seeking shareholder approval for the proposed AIM Delisting.

Reasons for the AIM Delisting

The Board has resolved, subject to shareholder approval, to implement the AIM Delisting for the following reasons:

•

The Board expects that delisting from AIM and maintaining a sole listing of ADSs representing the Company’s Ordinary Shares on Nasdaq will further enhance the liquidity of trading in the Company’s securities by combining on Nasdaq the volume of transactions from both markets (Nasdaq and AIM).

•

Delisting from AIM would remove certain complexities and duplication that comes with administering two listing regimes. For example, by simplifying shareholder communications and compliance with regulatory requirements and by reducing associated costs and demand for internal resources.

•

The Board expects that a Nasdaq-only listing structure will continue to attract the appropriate investor base and investment style, maximizing the Company’s ability to access deeper pools of capital, reflecting the Company’s global presence and aligning more closely with its peers in the global life science tools industry.

•

The Company will continue to attract research analyst coverage from industry participants knowledgeable of the global life science tools industry, driven by their current research of peer companies (many of which are Nasdaq-listed).

•

In addition, the Company maintains the option to use Nasdaq-listed ADSs as transaction consideration, providing more flexible financing for future acquisitions.

Accordingly, the Directors believe that it is in the best interests of the Company and its shareholders as a whole to cancel the admission of the Company’s Ordinary Shares to trading on AIM.

The Company is providing an opportunity for shareholders to deposit their Ordinary Shares with the Depositary in exchange for delivery of ADSs, without cost, in connection with the AIM Delisting prior to or on 14 December 2022 (being the date on which the AIM Delisting takes effect).

Effect of the AIM Delisting

If the Resolution is passed at the General Meeting, shareholders will no longer be able to buy and sell Ordinary Shares on AIM after 13 December 2022.

The section ‘Information for holders of Ordinary Shares’ below provides more detail on the process of depositing Ordinary Shares for delivery of ADSs.

As a company incorporated in England and Wales, the Company will continue to be subject to the requirements of the Companies Act 2006.

Following the AIM Delisting taking effect, the Company will no longer be subject to the AIM Rules for Companies or be required to retain the services of an independent nominated adviser. The Company will also no longer be required to comply with the continuing obligations set out in the Disclosure Guidance and Transparency Rules (the “DTRs”) of the Financial Conduct Authority (the “FCA”) or, provided the Company’s securities remain outside the scope of the regulation, UK MAR. In addition, the Company and its shareholders will no longer be subject to the provisions of the DTRs relating to the disclosure of changes in significant shareholdings in the Company. The Company will, however, continue to comply with all regulatory requirements for the Nasdaq listing of ADSs, including all applicable rules and regulations of the SEC.

Shareholders who continue to hold Ordinary Shares following the AIM Delisting will continue to be notified in writing of the availability of key documents on the Company’s website, including publication of annual reports and annual general meeting documentation. Holders of ADSs will be able to continue to access all such information via the Company’s website. Holders of Ordinary Shares and ADSs will both be eligible to receive any future dividends that may be declared.

Details of the application of the City Code to the Company following the AIM Delisting are set out below.

Following the announcement, and effective date, of the AIM Delisting, holders of Ordinary Shares may choose to sell or otherwise dispose of their Ordinary Shares rather than deposit such Ordinary Shares for delivery of ADSs. However, if significant, any such sales of Ordinary Shares could have a negative effect on the value of the Ordinary Shares, as well as the trading price of the ADSs, which could inhibit other shareholders’ ability to sell or dispose of their Ordinary Shares at current trading prices.

Information for holders of Ordinary Shares

If the Resolution is passed at the General Meeting, the Company’s Ordinary Shares will

continue to be traded on AIM until market close (4.30 p.m. London time) on 13 December 2022. Thereafter, holders of Ordinary Shares can still hold the Ordinary Shares, but there will be no public market in the United Kingdom on which the Ordinary Shares can be traded, and the Ordinary Shares will not be tradeable on Nasdaq in this form.

To sell Ordinary Shares on Nasdaq following the AIM Delisting, shareholders would need to deposit their Ordinary Shares for delivery of ADSs. Each ADS represents one Ordinary Share. This deposit can be made at any time, including before the AIM Delisting, subject in all cases to the provisions of, and the limitations set forth in, the Deposit Agreement. A copy of the Deposit Agreement has been filed as Exhibit 2.1 to the Company’s Annual Report on Form 20-F filed with the SEC on 14 March 2022. You may obtain a copy of the Deposit Agreement from the SEC’s website (www.sec.gov). Please refer to Commission File Number 333-249526 when retrieving such copy.

The Board considers that shareholders should consider depositing their Ordinary Shares for delivery of ADSs prior to the AIM Delisting on 14 December 2022 for the following reasons:

•

For those shareholders who hold their Ordinary Shares in certificated form and wish to deposit their Ordinary Shares for delivery of ADSs, the Company’s Receiving Agent, Equiniti, will facilitate, on the Company’s behalf, a block transfer process. Shareholders who hold their Ordinary Shares in certificated form will find enclosed a Certificated Transfer Form for use if they wish to deposit their Ordinary Shares for delivery of ADSs. Subject to the requisite documents being returned to Equiniti by the required deadline (being 5.00 p.m. UK time on 1 December 2022), Equiniti will arrange for the relevant Ordinary Shares to be transferred to and through Equiniti’s CREST account to the CREST account of the Custodian, which has been appointed by the Depositary to hold the Ordinary Shares upon deposit, so that the Depositary can arrange to deliver the corresponding number of ADSs. The Custodian, on behalf of the Depositary, will hold all deposited Ordinary Shares in a custody account for the benefit of the holders and beneficial owners of ADSs.

•

Shareholders who elect to deposit their Ordinary Shares for delivery of ADSs prior to the AIM Delisting will not incur a UK stamp duty, or SDRT, charge. However, it is expected that shareholders who elect to deposit their Ordinary Shares for delivery of ADSs following the AIM Delisting will incur a stamp duty, or SDRT, charge, at a rate of 1.5 per cent. of the market value of the Ordinary Shares being deposited, to the UK taxation authority, HMRC.

•

Ordinarily, shareholders who deposit their Ordinary Shares for delivery of ADSs are charged an ADS issuance fee, by the Depositary, of up to $0.05 per ADS. However, no ADS issuance fees will be charged to shareholders who elect to deposit their Ordinary Shares in connection with the AIM Delisting on or prior to 14 December 2022 (or such other date as when the AIM Delisting takes effect).

Shareholders who do not elect to participate in the block transfer process can utilise the services of a broker who is able to facilitate deposits of Ordinary Shares at the shareholder’s convenience.

Shareholders whose Ordinary Shares are held in uncertificated form in CREST and who wish to deposit their Ordinary Shares for delivery of ADSs, should contact their broker without delay to request that their Ordinary Shares are deposited. The Company advises holders of Ordinary Shares to seek independent financial advice regarding the AIM Delisting and the deposit of their Ordinary Shares for delivery of ADSs.

Information on the process to deposit Ordinary Shares for delivery of ADSs and the forms to be completed accompany the Circular. The information and contacts at the Company’s Receiving Agent, Equiniti, in respect of completion of the Certificated Transfer Form for certificated holders, and the Company’s ADS Depositary, Citi, are included on the Company’s website at corporate.abcam.com.

Existing holders of ADSs who do not also hold Ordinary Shares do not need to take any action in connection with the AIM Delisting.

If the Resolution is not passed at the General Meeting, all documents provided to Equiniti or Citi in relation to the deposit of Ordinary Shares for delivery of ADSs shall be of no effect and all original share certificates will be returned to shareholders by Equiniti.

UK tax treatment

The Company cannot and does not provide any form of taxation advice to shareholders and therefore shareholders are strongly advised to seek their own taxation advice to confirm the consequences of continuing to hold unlisted Ordinary Shares or depositing Ordinary Shares for delivery of ADSs.

The following summary does not constitute legal or tax advice and is not exhaustive. The Company’s understanding of the current position for individuals who are UK tax resident and UK domiciled for relevant tax purposes is as follows but it should be noted that the position on certain points is not free from uncertainty and that the Company has not taken steps to confirm the current position with HMRC. Therefore, the following should not be relied upon by shareholders without taking further advice (and the Company accepts no liability in respect of any such reliance on any information provided herein on taxation matters):

•

The AIM Delisting should not, in itself, alter the classification of the Ordinary Shares in terms of whether these qualify as unlisted / unquoted securities for the purposes of certain specific UK tax rules (notably, the UK inheritance tax business property relief rules), recognising that in October 2020, the Company completed a direct listing of ADSs on NASDAQ. Shareholders should be aware that HMRC has not published any detailed guidance on the treatment of ’ADSs’ for inheritance tax purposes to date.

•

Under HMRC’s stated practice, those shareholders who elect to deposit their holdings of Ordinary Shares for delivery of Nasdaq-listed ADSs should not be considered as disposing of the Ordinary Shares for UK capital gains tax purposes when transferring the shares to the Company’s ADS Depositary, Citi, in exchange for issue of ADSs on the basis that the shareholder retains beneficial ownership of the Ordinary Shares.

Shareholders who elect to deposit their holdings of Ordinary Shares for delivery of Nasdaq-listed ADSs prior to the AIM Delisting should not incur a stamp duty, or SDRT, charge. It is expected that shareholders who elect to deposit their holdings of Ordinary Shares for delivery of Nasdaq-listed ADSs following the AIM Delisting will generally incur a UK stamp duty, or SDRT, charge at the rate of 1.5 per cent. of the market value of the Ordinary Shares being deposited.

It is strongly recommended that shareholders obtain appropriate professional advice in respect of these and other taxes.

Further information in relation to the AIM Delisting

The Board believes that the proposed AIM Delisting is an appropriate next step for the Company and is in the best interests of shareholders as a whole. Further information about the process required to deposit Ordinary Shares for delivery of ADSs tradeable on Nasdaq, together with a set of Frequently Asked Questions, accompanies the Circular.

Action to be taken to deposit Ordinary Shares for delivery of ADSs

Shareholders are reminded that the Company’s Ordinary Shares will continue to be traded on AIM until market close (4.30 p.m. London time) on 13 December 2022. Any shareholder holding Ordinary Shares in certificated form who wishes to deposit their holding of Ordinary Shares for delivery of Nasdaq-listed ADSs prior to the AIM Delisting must submit their Certificated Transfer Form accompanying the Circular and their original share certificate(s) to Equiniti, so as to be received by Equiniti by no later than 5.00 p.m. on 1 December 2022 in

accordance with the instructions in the form.

Any shareholder holding shares in CREST who wishes to deposit their holding of Ordinary Shares for delivery of Nasdaq-listed ADSs prior to the AIM Delisting should contact their broker as soon as possible to deposit their Ordinary Shares.

If the Resolution is passed at the General Meeting, after AIM market close (4.30 p.m. London time) on 13 December 2022, holders of Ordinary Shares can still hold the Ordinary Shares, but there will be no public market in the United Kingdom on which the Ordinary Shares can be traded. It is expected that shareholders who elect to deposit their holdings of Ordinary Shares for delivery of Nasdaq listed ADSs following the AIM Delisting will incur a stamp duty, or SDRT, charge at the rate of 1.5 per cent. of the market value of the Ordinary Shares being deposited.

Existing holders of ADSs not also holding Ordinary Shares do not need to take any action in connection with the AIM Delisting.

In respect of any queries regarding completion of the Certificated Transfer Form, a shareholder assistance advice line is being operated by the Company’s Receiving Agent, Equiniti, which can be accessed by all shareholders on +44 (0) 333-207-5963. Calls are charged at the standard geographic rate and will vary by provider. Calls from outside the UK will be charged at the applicable international rate. Lines are open 8.30 a.m. to 5.30 p.m., Monday to Friday, excluding public holidays in England and Wales.

Application of the City Code following the AIM Delisting

Following the AIM Delisting shareholders will continue to benefit from the protection afforded by the Companies Act 2006 (as the Company remains incorporated in England and Wales). In addition, the Company may benefit from any applicable protections afforded by virtue of the Nasdaq listing of ADSs, as well as any applicable rules and regulations of the SEC.

The Panel on Takeovers and Mergers (“Panel”) has confirmed to the Company that following the AIM Delisting, based on the current composition of the Board, the City Code on Takeovers and Mergers (“City Code”) will not apply to the Company. However, the City Code could apply to the Company in the future if any changes to the Board composition result in the Panel considering that the Company has its place of central management and control in the United Kingdom (or the Channel Islands or the Isle of Man).

The City Code is issued and administered by the Panel. Abcam plc is a company to which the City Code applies and its shareholders are accordingly entitled to the protections afforded by the City Code. The City Code and the Panel operate principally to ensure that shareholders are treated fairly and are not denied an opportunity to decide on the merits of a takeover and that shareholders of the same class are afforded equivalent treatment by an offeror. The City Code also provides an orderly framework within which takeovers are conducted. In addition, it is designed to promote, in conjunction with other regulatory regimes, the integrity of the financial markets. You can view a copy of the code at https://www.thetakeoverpanel.org.uk/the-code.

way in which the test for central management and control is applied for the purposes of the City Code may be different from the way in which it is applied by the United Kingdom tax authorities, HMRC. Under the City Code, the Panel looks to where the majority of the directors of the Company are resident, amongst other factors, for the purposes of determining where the Company has its place of central management and control.

Shareholders should note that, if the AIM Delisting becomes effective and the City Code ceases to apply to the Company, they will not receive the protections afforded by the City Code in the event that there is a subsequent offer to acquire their shares.

Brief details of the Panel, the City Code and the protections given by the City Code are described in Appendix A to the Circular. Before giving your approval to the AIM Delisting, you may want to take independent professional advice from an appropriate independent financial adviser.

Shareholder questions

If you would like to ask a question of the Board relating to the business of the General Meeting, we invite you to send it by email to Company.Secretary@abcam.com. We will endeavour to respond to all questions asked via email after the General Meeting. Answers to common questions asked will also be published on the Company’s website.

The General Meeting

A notice convening the General Meeting, which is to be held at Discovery Drive, Cambridge Biomedical Campus, Cambridge, CB2 0AX United Kingdom at 2.00 p.m. (London time) on 11 November 2022 is set out at the end of the Circular. At the General Meeting, the Resolution will be proposed as a special resolution.

Recommendation

Your Board believes that the resolution contained in the Notice of Meeting is in the best interests of the Company and its shareholders as a whole. Accordingly, the Board unanimously recommends that shareholders vote in favour of the resolution to be proposed at the General Meeting, as the Company’s Directors intend to do in respect of their own beneficial shareholdings in the Company

Expected Timetable


Dispatch of the Circular and the accompanying documents		17 October 2022

Latest date for receipt of proxy voting instructions and (if applicable) hard copy forms of proxy		2.00 p.m. on 9 November 2022

General Meeting		2.00 p.m. on 11 November 2022

Last date for receipt by the Registrar from certificated shareholders of duly completed Certificated Transfer Forms and original share certificates		5.00 p.m. on 1 December 2022

Latest date for receipt by the Depositary from CREST holders of duly completed issuance forms		5.00 p.m. on 1 December 2022

Expected date for issuance of ADSs to block transfer participants		12 December 2022

Expected date of mailing of ADS confirmations to shareholders by the Depositary		13 December 2022

Last day of dealings in the Ordinary Shares on AIM		13 December 2022

Cancellation of admission to trading on AIM of the Ordinary Shares		7.00 a.m. on 14 December 2022

Notes

(1)	References to time in this announcement are to London time unless otherwise stated.

(2)	Each of the times and dates in the above timetable are subject to change. If any of the above times and/or dates change, the revised times and/or dates will be notified to shareholders by announcement through a Regulatory Information Service.

(3)

All steps after the General Meeting are dependent on the Resolution being passed at the General Meeting. If the Resolution is not passed at the General Meeting, all documents provided to the Registrar and/or the Depositary in relation to the deposit of Ordinary Shares for delivery of ADSs shall be of no effect and all original share certificates will be returned to shareholders by the Registrar.

Disclaimer

This announcement contains inside information as defined for the purposes of Article 7 of Regulation (EU) no. 596/2014, as it forms part of domestic law in the United Kingdom by virtue of the European Union (Withdrawal) Act 2018 (“UK MAR”).

This announcement shall not constitute an offer to sell or the solicitation of an offer to buy the Ordinary Shares or ADSs, nor shall there be any sale of the Ordinary Shares or ADSs in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction.

Neither this announcement nor the Circular forms part of an offer of transferable securities to the public in the United Kingdom and no prospectus has been, or is required to be, submitted to the FCA for approval.

Numis Securities Limited, which is a member of the London Stock Exchange, is authorised and regulated in the UK by the Financial Conduct Authority and is acting as nominated adviser to the Company and no one else for the purposes of the AIM Rules in connection with the AIM Delisting. Numis is not acting for, and will not be responsible to, any person other than the Company for providing the protections afforded to its customers or for advising any other person on the contents of this announcement or the AIM Delisting. Numis is not responsible for the contents of this announcement. Numis’ responsibilities as the Company’s nominated adviser under the AIM Rules are owed solely to the London Stock Exchange and are not owed to the Company, any Director, or to any other person.

Forward-Looking Statements

This announcement contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Any express or implied statements contained in this announcement that are not statements of historical fact may be deemed to be forward-looking statements, including, without limitation, statements regarding the implications of the AIM Delisting on the trading of the Company’s equity securities and related timing, as well as statements that include the words “expect,” “intend,” “plan,” “believe,” “project,” “forecast,” “estimate,” “may,” “should,” “anticipate” and similar statements of a future or forward-looking nature. Forward-looking statements are neither promises nor guarantees, but involve known and unknown risks and uncertainties that could cause actual results to differ materially from those projected, including, without limitation: the risk that anticipated trading volume in the Company’s equity securities on Nasdaq may not materialise; and the important factors discussed under the caption “Risk Factors” in Abcam’s Annual Report on Form 20-F for the year ended 31 December 2021, which is on file with the U.S. Securities and Exchange Commission (“SEC”) and is available on the SEC website at www.sec.gov, as such factors may be updated from time to time in Abcam’s other filings with the SEC. Any forward-looking statements contained in this announcement speak only as of the date hereof and accordingly undue reliance should not be placed on such statements. Abcam disclaims any obligation or undertaking to update or revise any forward-looking statements contained in

this announcement, whether as a result of new information, future events or otherwise, other than to the extent required by applicable law.

Enquiries:


Abcam plc Alan Hirzel, Chief Executive Officer Michael Baldock, Chief Financial Officer Tommy J. Thomas, CPA, Vice President, Investor Relations		+44 (0) 1223 696 000
Numis - Nominated Advisor & Joint Corporate Broker Freddie Barnfield / Duncan Monteith		+ 44 (0) 20 7260 1000
Morgan Stanley - Joint Corporate Broker Tom Perry / Luka Kezic		+ 44 (0) 20 7425 8000
FTI Consulting Ben Atwell / Julia Bradshaw / Lydia Jenkins		+ 44 (0) 20 3727 1000

About Abcam

As an innovator in reagents and tools, Abcam’s purpose is to serve life science researchers globally to achieve their mission faster. Providing the research and clinical communities with tools and scientific support, the Company offers highly validated antibodies, assays and other research tools to address important targets in critical biological pathways.

Already a pioneer in data sharing and ecommerce in the life sciences, Abcam’s ambition is to be the most influential company in life sciences by helping advance global understanding of biology and causes of disease, which, in turn, will drive new treatments and improved health.

Abcam’s worldwide customer base of approximately 750,000 life science researchers uses Abcam’s antibodies, reagents, biomarkers and assays. By actively listening to and collaborating with these researchers, the Company continuously advances its portfolio to address their needs. A transparent program of customer reviews and datasheets, combined with industry-leading validation initiatives, gives researchers increased confidence in their results.

Founded in 1998 and headquartered in Cambridge, UK, the Company has served customers in more than 130 countries. Abcam’s ordinary shares are listed on the London Stock Exchange (AIM: ABC) and its American Depositary Shares (ADSs) trade on the Nasdaq Global Market (Nasdaq: ABCM).

EX-99.2 3 d408355dex992.htm EX-99.2 EX-99.2

Exhibit 99.2

THIS DOCUMENT AND THE ACCOMPANYING DOCUMENTS ARE IMPORTANT AND REQUIRE YOUR IMMEDIATE ATTENTION. If you are in any doubt as to any aspect of the proposals referred to in this Document, please consult your stockbroker, bank manager, solicitor, accountant or other independent adviser.

If you have sold or otherwise transferred all of your Ordinary Shares, please send this Document, together with the accompanying documents (but not the personalised Form of Proxy), as soon as possible to the purchaser or transferee, or to the stockbroker, bank or other agent through whom the sale or transfer was effected, for delivery to the purchaser or transferee.

For you to be able to attend and vote at the meeting, your ownership of shares must be registered at Equiniti Limited, Aspect House, Spencer Road, Lancing, West Sussex BN99 6DA by 2.00 p.m. on 9 November 2022.

LOGO

Proposed Cancellation of Admission of Ordinary Shares to Trading on AIM

and

Notice of General Meeting

A notice convening a General Meeting of Abcam plc is set out on pages 13 to 14 of this Document.

The General Meeting will be held on

11 November 2022 at 2.00 p.m. at

Discovery Drive

Cambridge Biomedical Campus

Cambridge, CB2 0AX

United Kingdom

Numis Securities Limited, which is a member of the London Stock Exchange, is authorised and regulated in the UK by the Financial Conduct Authority and is acting as nominated adviser to the Company and no one else for the purposes of the AIM Rules in connection with the AIM Delisting. Numis is not acting for, and will not be responsible to, any person other than the Company for providing the protections afforded to its customers or for advising any other person on the contents of this Document or the AIM Delisting. Numis is not responsible for the contents of this document. Numis’ responsibilities as the Company’s nominated adviser under the AIM Rules are owed solely to the London Stock Exchange and are not owed to the Company, any Director, or to any other person.

Cautionary note regarding forward-looking statements

This Document contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Any express or implied statements contained in this Document that are not statements of historical fact may be deemed to be forward-looking statements, including, without limitation, statements regarding the Company’s expectations surrounding the AIM Delisting, as well as statements that include the words “expect,” “intend,” “plan,” “believe,” “project,” “forecast,” “estimate,” “may,” “should,” “anticipate” and similar statements of a future or forward-looking nature. Forward-looking statements are neither promises nor guarantees, but involve known and unknown risks and uncertainties that could cause actual results to differ materially from those projected, including, without limitation: a regional or global health pandemic, including the novel coronavirus and its related variants (“COVID-19”), which has adversely affected elements of our business, could severely affect our business, including due to impacts on our operations and supply chains; challenges in implementing our strategies for revenue growth in light of competitive challenges; developing new products and enhancing existing products, adapting to significant technological change and

responding to the introduction of new products by competitors to remain competitive; failing to successfully identify or integrate acquired businesses or assets into our operations or fully recognize the anticipated benefits of businesses or assets that we acquire; if our customers discontinue or spend less on research, development, production or other scientific endeavours; failing to successfully use, access and maintain information systems and implement new systems to handle our changing needs; cyber security risks and any failure to maintain the confidentiality, integrity and availability of our computer hardware, software and internet applications and related tools and functions; failing to successfully manage our current and potential future growth; any significant interruptions in our operations; if our products fail to satisfy applicable quality criteria, specifications and performance standards; failing to maintain our brand and reputation; our dependence upon management and highly skilled employees and our ability to attract and retain these highly skilled employees; and the important factors discussed under the caption “Risk Factors” in the Company’s Annual Report on Form 20-F for the year ended 31 December 2021 filed with the U.S. Securities and Exchange Commission (“SEC”) on 14 March 2022, which is on file with the SEC and is available on the SEC website at www.sec.gov, as such factors may be updated from time to time in the Company’s other filings with the SEC. Any forward-looking statements contained in this Document speak only as of the date hereof and accordingly undue reliance should not be placed on such statements. The Company disclaims any obligation or undertaking to update or revise any forward-looking statements contained in this Document, whether as a result of new information, future events or otherwise, other than to the extent required by applicable law.

Notice to overseas persons

The distribution of this Document in certain jurisdictions may be restricted by law and therefore persons into whose possession this Document comes should inform themselves about and observe any such restrictions. Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdiction.

CONTENTS


EXPECTED TIMETABLE			4

PROPOSED CANCELLATION OF ADMISSION OF ORDINARY SHARES TO TRADING ON AIM AND NOTICE OF GENERAL MEETING			5

DEFINITIONS			11

NOTICE OF GENERAL MEETING			13

APPENDIX			17

EXPECTED TIMETABLE


Dispatch of this Document and the accompanying documents		17 October 2022

Latest date for receipt of proxy voting instructions and (if applicable) hard copy forms of proxy		2.00 p.m. on 9 November 2022

General Meeting		2.00 p.m. on 11 November 2022

Last date for receipt by the Registrar from certificated shareholders of duly completed Certificated Transfer Forms and original share certificates		5.00 p.m. on 1 December 2022

Latest date for receipt by the Depositary from CREST holders of duly completed issuance forms		5.00 p.m. on 1 December 2022

Expected date for issuance of ADSs to block transfer participants		12 December 2022

Expected date of mailing of ADS confirmations to shareholders by the Depositary		13 December 2022

Last day of dealings in the Ordinary Shares on AIM		13 December 2022

Cancellation of admission to trading on AIM of the Ordinary Shares		7.00 a.m. on 14 December 2022

Notes

(1)	References to time in this Document are to London time unless otherwise stated.

(2)	Each of the times and dates in the above timetable are subject to change. If any of the above times and/or dates change, the revised times and/or dates will be notified to shareholders by announcement through a Regulatory Information Service.

(3)

Directors

Peter Allen (Chairman)

Alan Hirzel (Chief Executive Officer)

Michael S Baldock (Chief Financial Officer)

Mara Aspinall (Non-Executive Director)

Mark Capone (Non-Executive Director)

Sally W Crawford (Non-Executive Director)

Giles Kerr (Senior Independent Director)

Bessie Lee (Non-Executive Director)

Luba Greenwood (Non-Executive Director)

Registered and Head Office

Abcam plc

Discovery Drive

Cambridge Biomedical Campus

Cambridge, CB2 0AX

United Kingdom

17 October 2022

Dear Shareholder

Proposed Cancellation of Admission of Ordinary Shares to Trading on AIM

and

Notice of General Meeting

I am pleased to enclose the Notice for a General Meeting of Abcam plc which is set out on pages 13 to 14 of this Document. The General Meeting will be held on 11 November 2022 at Abcam plc, Discovery Drive, Cambridge Biomedical Campus, Cambridge, CB2 0AX United Kingdom at 2 p.m.

Introduction and purpose of the General Meeting

On 14 March 2022, the Board announced its intention to consult with shareholders on options to increase share liquidity. Following this consultation, the Board announced on 20 July 2022 that it intended to consult further with shareholders on a proposal to cancel the admission of the Company’s Ordinary Shares to trading on AIM, in order to maintain a sole listing on Nasdaq. Having consulted with shareholders holding more than 75 per cent. of the Company’s total shares outstanding and received overwhelmingly positive responses from shareholders consulted, the Board is calling a General Meeting to formally approve the cancellation of the admission of the Company’s Ordinary Shares to trading on AIM (the “AIM Delisting”).

Following the AIM Delisting, ADSs representing the Company’s Ordinary Shares will remain listed on Nasdaq and all public trading of securities in the Company will take place on that single exchange.

This letter is intended to provide you with the background to and reasons for the AIM Delisting, and to explain why the Board considers the AIM Delisting to be in the best interests of the Company and its shareholders as a whole and recommends that you vote in favour of the Resolution at the General Meeting.

If the Resolution is approved at the General Meeting, the AIM Delisting will take effect on 14 December 2022 and the last day of trading of Ordinary Shares on AIM will be 13 December 2022. By providing shareholders with substantial advance notice, together with clear guidance as to how to deposit Ordinary Shares for delivery of ADSs listed on Nasdaq, it is expected that shareholders who wish to deposit their Ordinary Shares will be able to do so with relative ease.

Background

The Company was incorporated in 1998 and its Ordinary Shares have been admitted to trading on the AIM market of the London Stock Exchange since 2005. In October 2020, the Company completed a direct listing of ADSs representing 10,287,000 Ordinary Shares on Nasdaq. The listing of the ADSs on Nasdaq provided the Company with access to a broader US investor base in particular, from long-term life science investors; access to deeper US capital pools; and provided additional liquidity for the Company’s shareholders.

Since the listing of the ADSs on Nasdaq in October 2020, the number of Ordinary Shares, represented by ADSs, that are tradeable on Nasdaq has approximately tripled. As at 12 October 2022, being the last practicable date prior to the date of this Document, approximately 14 per cent. of the Company’s Ordinary Shares are represented by ADSs tradeable on Nasdaq. While only 14 per cent. of our Ordinary Shares trade through ADSs in the US market, it represents approximately 24 per cent. of the overall average daily volume of the Ordinary Shares on both AIM and Nasdaq over the past one month to 12 October 2022.

Reasons for the AIM Delisting

The Board has resolved, subject to shareholder approval, to implement the AIM Delisting for the following reasons:

•

In addition, the Company maintains the option to use Nasdaq-listed ADSs as transaction consideration, providing more flexible financing for future acquisitions.

Accordingly, the Directors believe that it is in the best interests of the Company and its shareholders as a whole to cancel the admission of the Company’s Ordinary Shares to trading on AIM.

Effect of the AIM Delisting

If the Resolution is passed at the General Meeting, shareholders will no longer be able to buy and sell Ordinary Shares on AIM after 13 December 2022.

The section ‘Information for holders of Ordinary Shares’ below provides more detail on the process of depositing Ordinary Shares for delivery of ADSs.

As a company incorporated in England and Wales, the Company will continue to be subject to the requirements of the Companies Act 2006.

Following the AIM Delisting taking effect, the Company will no longer be subject to the AIM Rules for Companies or be required to retain the services of an independent nominated adviser. The Company will also no longer be required to comply with the continuing obligations set out in the DTRs or, provided the Company’s securities remain outside the scope of the regulation, UK MAR. In addition, the Company and its shareholders will no longer be subject to the provisions of the DTRs relating to the disclosure of changes in significant shareholdings in the Company. The Company will, however, continue to comply with all regulatory requirements for the Nasdaq listing of ADSs, including all applicable rules and regulations of the SEC.

Shareholders who continue to hold Ordinary Shares following the AIM Delisting will continue to be notified in

writing of the availability of key documents on the Company’s website, including publication of annual reports and annual general meeting documentation. Holders of ADSs will be able to continue to access all such information via the Company’s website. Holders of Ordinary Shares and ADSs will both be eligible to receive any future dividends that may be declared.

Details of the application of the City Code to the Company following the AIM Delisting are set out below.

Information for holders of Ordinary Shares

If the Resolution is passed at the General Meeting, the Company’s Ordinary Shares will continue to be traded on AIM until market close (4.30 p.m. London time) on 13 December 2022. Thereafter, holders of Ordinary Shares can still hold the Ordinary Shares, but there will be no public market in the United Kingdom on which the Ordinary Shares can be traded, and the Ordinary Shares will not be tradeable on Nasdaq in this form.

The Board considers that shareholders should consider depositing their Ordinary Shares for delivery of ADSs prior to the AIM Delisting on 14 December 2022 for the following reasons:

•

Information on the process to deposit Ordinary Shares for delivery of ADSs and the forms to be completed accompany this Document. The information and contacts at the Company’s Receiving Agent, Equiniti, in respect of completion of the Certificated Transfer Form for certificated holders, and the Company’s ADS Depositary, Citi, are included on the Company’s website at corporate.abcam.com.

Existing holders of ADSs who do not also hold Ordinary Shares do not need to take any action in connection with the AIM Delisting.

UK tax treatment

•

The AIM Delisting should not, in itself, alter the classification of the Ordinary Shares in terms of whether these qualify as unlisted / unquoted securities for the purposes of certain specific UK tax rules (notably, the UK inheritance tax business property relief rules), recognising that in October 2020, the Company completed a direct listing of ADSs on Nasdaq. Shareholders should be aware that HMRC has not published any detailed guidance on the treatment of ’ADSs’ for inheritance tax purposes to date.

•

It is strongly recommended that shareholders obtain appropriate professional advice in respect of these and other taxes.

Further information in relation to the AIM Delisting

Action to be taken to deposit Ordinary Shares for delivery of ADSs

Shareholders are reminded that the Company’s Ordinary Shares will continue to be traded on AIM until market close (4.30 p.m. London time) on 13 December 2022. Any shareholder holding Ordinary Shares in certificated form who wishes to deposit their holding of Ordinary Shares for delivery of Nasdaq-listed ADSs prior to the AIM Delisting must submit their Certificated Transfer Form accompanying this letter and their original share certificate(s) to Equiniti, so as to be received by Equiniti by no later than 5.00 p.m. on 1 December 2022 in accordance with the instructions in the form.

Existing holders of ADSs not also holding Ordinary Shares do not need to take any action in connection with the AIM Delisting.

Application of the City Code following the AIM Delisting

Following the AIM Delisting, as the Company will remain a public limited company incorporated in England and Wales but its securities will not be admitted to trading on a regulated market or multilateral trading facility in the United Kingdom (or a stock exchange in the Channel Islands or the Isle of Man), the City Code will only apply to the Company if it is considered by the Panel to have its place of central management and control in the United Kingdom (or the Channel Islands or the Isle of Man). This is known as the “residency test”. The way in which the test for central management and control is applied for the purposes of the City Code may be different from the way in which it is applied by the United Kingdom tax authorities, HMRC. Under the City Code, the Panel looks to where the majority of the directors of the Company are resident, amongst other factors, for the purposes of determining where the Company has its place of central management and control.

Brief details of the Panel, the City Code and the protections given by the City Code are described in Appendix

to this Document. Before giving your approval to the AIM Delisting, you may want to take independent professional advice from an appropriate independent financial adviser.

Shareholder questions

The General Meeting

A notice convening the General Meeting, which is to be held at Discovery Drive, Cambridge Biomedical Campus, Cambridge, CB2 0AX United Kingdom at 2.00 p.m. (London time) on 11 November 2022 is set out at the end of this Document. At the General Meeting, the Resolution will be proposed as a special resolution.

The Resolution will be proposed as a special resolution to approve the cancellation of the admission to trading on AIM of the Ordinary Shares and to authorise the Directors to take all action reasonable or necessary to effect such cancellation.

Voting on resolutions will be by way of a poll, based on the proxy instructions received. Further details on voting are set out on pages 15 to 16 of this Document. All shareholders are encouraged to vote by proxy in accordance with the instructions set out on pages 15 to 16 of this Document. A Form of Proxy is enclosed with this Document.

You are asked to complete and sign it in accordance with the instructions printed thereon and return it to the Company’s Registrar by no later than 2.00 p.m. on 9 November 2022.

We encourage all shareholders to appoint the chairman of the General Meeting as their proxy to exercise their right to vote at the General Meeting in accordance with their instructions. This will ensure that their vote will be counted if ultimately they (or any other proxy they might otherwise appoint) are not able to attend the meeting.

The results of the General Meeting will be made available on the Company’s website.

Recommendation

Your Board believes that the resolution contained in the Notice of Meeting is in the best interests of the Company and its shareholders as a whole. Accordingly, the Board unanimously recommends that you vote in favour of the resolution to be proposed at the General Meeting, as your Directors intend to do in respect of their own beneficial shareholdings in the Company

Yours faithfully,

Peter Allen

Chairman

17 October 2022

DEFINITIONS


ADSs		American Depositary Shares, each representing one Ordinary Share;

AIM		AIM, a market operated by the London Stock Exchange;

AIM Delisting		the cancellation of the admission of the Ordinary Shares to trading on AIM;

AIM Rules for Companies		the rules and guidance for companies whose shares are admitted to trading on AIM entitled “AIM Rules for Companies” published by the London Stock Exchange as amended from time to time;

Circular or Document		this circular prepared in relation to the AIM Delisting and the General Meeting;

City Code		the City Code on Takeovers and Mergers;

Company		Abcam plc;

CREST		the computerised settlement system to facilitate transfer of title to or interest in securities in uncertificated form operated by Euroclear UK & International Limited;

Deposit Agreement		the New York law governed deposit agreement dated 26 October 2020 between the Company, the Depositary and all holders and beneficial owners of ADSs issued thereunder;

Depositary or Citi		Citibank, N.A.;

Directors or Board		the directors of the Company as at the date of this Document and whose names are stated at the beginning of this Document;

DTRs		the Disclosure Guidance and Transparency Rules of the FCA;

FCA		the Financial Conduct Authority;

General Meeting		the General Meeting of the Company, notice of which is set out at the end of this Document;

HMRC		Her Majesty’s Revenue & Customs;

London Stock Exchange		London Stock Exchange plc;

Nasdaq		the Nasdaq Global Select Market;

Notice of General Meeting		the notice convening the General Meeting as set out at the end of this Document;

Numis		Numis Securities Limited, the Company’s nominated adviser;

Ordinary Shares		ordinary shares of £0.002 each in the capital of the Company;

Panel		the Panel on Takeovers and Mergers;

Receiving Agent		Equiniti Limited;

Registrar		Equiniti Limited;

Resolution		the resolution to be proposed at the General Meeting as set out in the Notice of General Meeting;

Securities Act		the U.S. Securities Act of 1933, as amended;

SEC		the U.S. Securities and Exchange Commission;

SDRT		Stamp Duty Reserve Tax;

UK or United Kingdom		the United Kingdom of Great Britain and Northern Ireland;

UK MAR		Regulation (EU) No.596/2014 which forms part of domestic law in the United Kingdom pursuant to the European Union (Withdrawal) Act 2018; and


US or United States		the United States of America.

Notice of General Meeting

NOTICE is hereby given that a General Meeting of Abcam plc (“Company”) will be held on 11 November 2022 at Discovery Drive, Cambridge Biomedical Campus, Cambridge, CB2 0AX United Kingdom at 2.00 p.m. to consider and, if thought fit, pass the following resolution.

The resolution will be proposed as a special resolution.

Special business

THAT, in accordance with Rule 41 of the AIM Rules for Companies, the cancellation of the admission to trading on AIM of the ordinary shares of £0.002 each in the capital of the Company be and is hereby approved and the directors of the Company be authorised to take all action reasonable or necessary to effect such cancellation.

By order of the Board

Marc Perkins

Company Secretary

17 October 2022

Registered office:

Discovery Drive

Cambridge Biomedical Campus

Cambridge, CB2 0AX

United Kingdom

Explanatory notes to the business of the General Meeting

Resolution – cancellation of admission of Ordinary Shares to trading on AIM

It was announced, on 20 July 2022, that the Board had decided, following consultation with shareholders on options to increase share liquidity as announced on 14 March 2022, to pursue a proposal to maintain a sole listing on Nasdaq and, therefore, to cancel the admission of the Company’s Ordinary Shares to trading on AIM. In accordance with Rule 41 of the AIM Rules for Companies, the Directors are seeking authorisation to take all action reasonable or necessary to effect the AIM Delisting.

Notes

A member entitled to attend and vote at the General Meeting may appoint one or more proxies (who need not be members of the Company), provided that each proxy is appointed to exercise the rights attached to a different share or shares held by him or her, to attend, to speak and, on a poll, to vote on his or her behalf. It is advised however that shareholders appoint the Chairman only. A Form of Proxy is enclosed for use by shareholders. In order to be valid, a proxy appointment must be returned (together with any authority under which it is executed, or a copy of the authority certified in ink by a bank, a stockbroker or a solicitor) by one of the following methods:

•

In hard copy form by post, by courier to the Company’s registrar, Equiniti, at the address shown on the Proxy.

•

Online at www.sharevote.co.uk where full instructions on the procedure are given. The Voting ID, Task ID and Shareholder Reference Number printed on the Form of Proxy will be required to use this electronic proxy appointment system. Alternatively, shareholders who have already registered with Equiniti’s online portfolio service, Shareview, can appoint their proxy electronically by logging on to their portfolio at www.shareview.co.uk using their user ID and password. Once logged in click ‘View’ on the ‘My Investments’ page, click on the link to vote and then follow the on-screen instructions.

The appointment of a proxy in each case must be formally received by the Company’s registrar by no later than 2.00 p.m. on 9 November 2022.

Appointment of a proxy does not preclude a member of the Company from attending the General Meeting and voting in person.

If you are a member of CREST, you may register the appointment of a proxy by using the CREST electronic proxy appointment service. Further details are contained below:

CREST members who wish to appoint a proxy or proxies through the CREST electronic proxy appointment service may do so for the General Meeting and any adjournment(s) thereof by using the procedures described in the CREST Manual (available via www.euroclear.com). CREST personal members or other CREST sponsored members, and those CREST members who have appointed a voting service provider(s), should refer to their CREST sponsor or voting service provider(s), who will be able to take the appropriate action on their behalf.

In order for a proxy appointment or instruction made using the CREST service to be valid, the appropriate CREST message (a CREST Proxy Instruction) must be properly authenticated in accordance with Euroclear UK and Ireland Limited’s (Euroclear) specifications and must contain the information required for such instructions, as described in the CREST Manual. The message, regardless of whether it constitutes the appointment of a proxy or an amendment to the instruction given to a previously appointed proxy, must, in order to be valid, be transmitted so as to be received by the issuer’s agent (ID RA19) by the latest time(s) for receipt of proxy appointments specified in these notes. For this purpose, the time of receipt will be taken to be the time (as determined by the timestamp applied to the message by the CREST Applications Host) from which the issuer’s agent is able to retrieve the message by enquiry to CREST in the manner prescribed by CREST. After this time any change of instructions to proxies appointed through CREST should be communicated to the appointee through other means.

CREST members and, where applicable, their CREST sponsors or voting service provider(s) should note that Euroclear does not make available special procedures in CREST for any particular messages. Normal system timings and limitations will therefore apply in relation to the input of CREST Proxy Instructions. It is the

responsibility of the CREST member concerned to take (or, if the CREST member is a CREST personal member or sponsored member or has appointed a voting service provider(s), to procure that his CREST sponsor or voting service provider(s) take(s)) such action as shall be necessary to ensure that a message is transmitted by means of the CREST system by any particular time. In this connection, CREST members and, where applicable, their CREST sponsors or voting service provider(s) are referred, in particular, to those sections of the CREST Manual concerning practical limitations of the CREST system and timings.

The Company may treat as invalid a CREST Proxy Instruction in the circumstances set out in Regulation 35(5)(a) of the Uncertificated Securities Regulations 2001.

Pursuant to Regulation 41 of the Uncertificated Securities Regulations 2001, in order to be able to attend and vote at the General Meeting (and also for the purposes of calculating how many votes a person may cast), a person must have his/her name entered on the register of members of the Company by 2.00 p.m. on 9 November 2022 (or, if the General Meeting is adjourned, by 2.00 p.m. on the date which is two working days before the adjourned General Meeting). Changes to entries on the register of members after this time shall be disregarded in determining the rights of any person to attend or vote at the meeting.

As at 12 October 2022 (being the last practicable business day prior to the publication of this Notice) the Company’s issued share capital consists of 229,039,310 ordinary shares, carrying one vote each. Therefore, the total voting rights in the Company as at 12 October 2022 are 229,039,310.

You may not use any electronic address (within the meaning of section 333(4) of the Act) provided in this Notice of Meeting (or in any related documents including the Chairman’s letter and Form of Proxy) to communicate with the Company for any purposes other than those expressly stated.

Under section 338 of the Act, members meeting the threshold requirements in those sections have the right to require the Company: (i) to give, to members of the Company entitled to receive notice of the meeting, notice of a resolution which may properly be moved and is intended to be moved at the meeting; and/or (ii) to include in the business to be dealt with at the meeting any matter (other than a proposed resolution) which may be properly included in the business. A resolution may properly be moved or a matter may properly be included in the business unless (a) (in the case of a resolution only) it would, if passed, be ineffective (whether by reason of inconsistency with any enactment or the Company’s constitution or otherwise), (b) it is defamatory of any person, or (c) it is frivolous or vexatious. Such a request may be in hard copy form or in electronic form, must identify the resolution of which notice is to be given or the matter to be included in the business, must be authorised by the person or persons making it, must be received by the Company not later than the date which is six clear weeks before the General Meeting, and (in the case of a matter to be included in the business only) must be accompanied by a statement setting out the grounds for the request.

A corporation which is a shareholder may appoint one or more corporate representatives who may exercise on its behalf all its powers as a member provided that no more than one corporate representative exercises powers over the same share.

APPENDIX

The City Code

The City Code is issued and administered by the Panel. The City Code and the Panel operate principally to ensure that shareholders are treated fairly and are not denied an opportunity to decide on the merits of a takeover and that shareholders of the same class are afforded equivalent treatment by an offeror. The City Code also provides an orderly framework within which takeovers are conducted. In addition, it is designed to promote, in conjunction with other regulatory regimes, the integrity of the financial markets.

The General Principles and Rules of the City Code

The City Code is based upon a number of General Principles which are essentially statements of standards of commercial behaviour. The General Principles apply to all transactions with which the City Code is concerned. They are expressed in broad general terms and the City Code does not define the precise extent of, or the limitations on, their application. They are applied by the Panel in accordance with their spirit to achieve their underlying purpose.

In addition to the General Principles, the City Code contains a series of Rules, of which some are effectively expansions of the General Principles and examples of their application and others are provisions governing specific aspects of takeover procedure. Although most of the Rules are expressed in more detailed language than the General Principles, they are not framed in technical language and, like the General Principles, are to be interpreted to achieve their underlying purpose. Therefore, their spirit must be observed as well as their letter. The Panel may derogate or grant a waiver to a person from the application of a Rule in certain circumstances.

Giving up the protection of the City Code

The following is a summary of key provisions of the City Code which apply to transactions to which the City Code applies. You are encouraged to read this information carefully as it outlines certain important protections which you will be giving up if you agree to the AIM Delisting.

•

Equality of treatment

General Principle 1 of the City Code states that all holders of the securities of an offeree company of the same class must be afforded equivalent treatment. Furthermore, Rule 16.1 requires that, except with the consent of the Panel, special arrangements may not be made with certain shareholders in the Company if there are favourable conditions attached which are not being extended to all shareholders.

•

Information to shareholders

General Principle 2 requires that the holders of the securities of an offeree company must have sufficient time and information to enable them to reach a properly informed decision on the takeover bid. Consequently, a document setting out full details of an offer must be sent to the offeree company’s shareholders.

•

The opinion of the offeree board and independent advice

The board of the offeree company is required by Rule 3.1 of the City Code to obtain competent independent advice as to whether the financial terms of an offer are fair and reasonable and the substance of such advice must be made known to shareholders. Rule 25.2 requires the board of the offeree company to send to shareholders and persons with information rights its opinion on the offer and its reasons for forming that opinion. That opinion must include the board’s views on: (i) the effects

of implementation of the offer on all the company’s interests, including, specifically, employment; and (ii) the offeror’s strategic plans for the offeree company and their likely repercussions on employment and the locations of the offeree company’s places of business.

The document sent to shareholders must also deal with other matters such as interests and recent dealings in the securities of the offeror and the offeree company by relevant parties and whether the directors of the offeree company intend to accept or reject the offer in respect of their own beneficial shareholdings.

Rule 20.1 states that, except in certain circumstances, information and opinions relating to an offer or a party to an offer must be made equally available to all offeree company shareholders and persons with information rights as nearly as possible at the same time and in the same manner.

•

Option holders and holders of convertible securities or subscription rights

Rule 15 of the City Code provides that when an offer is made and the offeree company has convertible securities outstanding, the offeror must make an appropriate offer or proposal to the holders of those securities to ensure their interests are safeguarded. Rule 15 also applies in relation to holders of options and other subscription rights.

LOGO

Abcam plc

Discovery Drive

Cambridge Biomedical Campus

Cambridge, CB2 0AX

United Kingdom

Email:

company.secretary@abcam.com

Phone: +44 (0)1223 696000

Fax: +44 (0)1223 215215

EX-99.3 4 d408355dex993.htm EX-99.3 EX-99.3

Exhibit 99.3

Attendance Card

Abcam plc – General Meeting


		Notice of availability
		Please note that, depending on your election, hard copies of Abcam plc’s Notice of General Meeting may not be enclosed. Both documents are, however, available on the Company’s website at corporate.abcam.com.

		If at any point you should wish to opt out of receiving documents and information via our website, then you may do so in writing, sent to our registrars at Equiniti Limited, Aspect House, Spencer Road, Lancing, West Sussex BN99 8LU.

		Deadline for receipt of Form of Proxy
		The deadline for the receipt of your Form of Proxy for the General Meeting by our registrars, Equiniti Limited, is 2.00pm on Wednesday 9 November 2022.

		Further details relating to the appointment of proxies are provided in the notes to the Form of Proxy which are printed overleaf.
The General Meeting is to be held at 2.00 pm on Friday 11 November 2022 at the offices of Abcam plc, Discovery Drive, Cambridge Biomedical Campus, Cambridge CB4 0AX.

If you wish to attend this meeting in your capacity as a holder of ordinary shares, please sign this card and on arrival hand it to the Company’s registrars. This will facilitate entry to the meeting.

Signature of

person attending

Shareholder

reference number


Form of Proxy
Abcam plc – General Meeting


Voting ID	Task ID	Shareholder Reference Number



I/We being a member(s) of the Company hereby appoint the Chairman of the Meeting or (see note 1 overleaf)

Name of Proxy

Number of shares

proxy appointed over:


as my/our proxy to vote on my/our behalf at the General Meeting of the Company to be held at 2.00 pm on Friday 11 November 2022 and at any adjournment thereof. I/We have indicated with a X how I/we wish my/our votes to be cast on the following resolution.

If you wish to appoint multiple proxies, please see note 1 overleaf.		☐ Please also tick here if you are appointing more than one proxy.


Resolution
Please mark X to indicate how you wish to vote
1.		In accordance with Rule 41 of the AIM Rules for Companies, to cancel the admission to trading on AIM of the ordinary shares of £0.002 each in the capital of the Company to authorise the directors of the Company to take all action reasonable or necessary to effect such cancellation.

LOGO

Signature

Date

Notes

1. Every holder has the right to appoint some other person(s) of their choice, who need not be a shareholder but must attend the meeting, as his/her proxy to exercise all or any of his/her rights, to attend, speak and vote on their behalf at the meeting. If you wish to appoint a person other than the Chairman, please insert the full name of your chosen proxy holder in the space provided (see over). If you sign and return this form with no name inserted in the box, the Chairman will be deemed to be your proxy. If the proxy is being appointed in relation to less than your full voting entitlement, please enter the number of shares in relation to which they are authorised to act as your proxy. If left blank, your proxy will be deemed to be authorised in respect of your full voting entitlement (or if this Form of Proxy has been issued in respect of a designated account for a shareholder, the full voting entitlement for that designated account).

2. To appoint more than one proxy you may photocopy this form. Please indicate the proxy holder’s name and the number of shares in relation to which they are authorised to act as your proxy (which, in aggregate, should not exceed the number of shares held by you). Please also indicate if the proxy instruction is one of multiple instructions being given. All forms must be signed and should be returned together in the same envelope. If sending from outside the UK, the correct postage will need to be applied.

3. In the case of joint members, any one of such members may vote at the General Meeting and if more than one of such joint members is present either personally or by proxy, the vote of the most senior who tenders a vote will be accepted to the exclusion of the votes of the other registered members. Seniority is determined by the order in which the names stand in the register. In the case of joint members, only one needs to sign the proxy.

4. If the appointer is a corporation, the Form of Proxy should be executed under its common seal or signed by a duly authorised officer or attorney or otherwise in accordance with section 44 of the Companies Act 2006. The appropriate power of attorney or other authority should be returned with the form.

5. To direct your proxy how to vote on the resolution being proposed at the meeting mark the appropriate box with an “X”. If no voting indication is given, your proxy will vote, or abstain from voting, at his or her discretion. Your proxy will vote (or abstain from voting) as he or she thinks fit in relation to any other matter which is put before the meeting.

6. The ‘Vote withheld’ option is provided to enable you to abstain on the resolution. However, it should be noted that a ‘Vote withheld’ is not a vote in law and will not be counted in the calculation of the proportion of the votes ‘For’ and ‘Against’ the resolution.

7. Entitlement to attend and vote at the meeting and the number of votes which may be cast thereat will be determined by reference to the Register of Members of the Company as at 6:30pm on Wednesday 9 November 2022 (or, in the case of any adjournment of the meeting, no later than 48 hours (excluding any part of a day that is not a business day) before the time appointed for the holding of the adjourned meeting). Changes to entries on the Register of Members after that time shall be disregarded in determining the rights of any person to attend and vote at the meeting.

8. Any shareholder who holds through CREST and who wishes to appoint a proxy through the CREST proxy voting service for the meeting may do so by using the procedures described in the CREST Manual (available at https://www.euroclear.com/en.html). To appoint a proxy or to give or amend an instruction to a previously appointed proxy via the CREST system, the CREST message must be received by the issuer’s agent (ID RA19) by 2:00pm on Wednesday 9 November 2022. For this purpose, the time of receipt will be taken to be the time (as determined by the timestamp applied to the message by the CREST Applications Host) from which the issuer’s agent is able to retrieve the message. After this time any change of instructions to a proxy appointed through CREST should be communicated to the proxy by other means. CREST personal members or other CREST sponsored members and those CREST members who have appointed voting service provider(s) should contact their CREST sponsor or voting service provider(s) for assistance with appointing proxies via CREST. For further information on CREST procedures, limitations and system timings please refer to the CREST Manual. We may treat as invalid a proxy appointment sent by CREST in the circumstances set out in Regulation 35(5)(a) of the Uncertificated Securities Regulations 2001. In any case your Form of Proxy must be received by the Company’s registrars no later than 2:00pm on Wednesday 9 November.

9. The completion and return of this form will not preclude a member from attending the meeting and voting in person. If you attend the meeting in person, your proxy appointment will automatically be terminated.

10. If two or more valid but different instruments of proxy are delivered in respect of the same share for use at the General Meeting, the one which is last validly deposited or received shall be treated as replacing and revoking the other proxy as regarding the share. Which proxy is later will be determined on the basis of which proxy is last sent (or, if the Company is unable to determine which is last sent, last received). Proxies in the same envelope will be treated as sent and received at the same time, to minimise the number of conflicting proxies. If conflicting proxies are sent or received at the same time or if the Company is unable to determine which was sent or received last in respect of (or deemed to be in respect of) an entire holding, none of them shall be treated as valid).

11. If you prefer, you may return the Form of Proxy to the registrars in an envelope addressed to Equiniti Limited, FREEPOST RTHJ-CLLL-KBKU, Aspect House, Spencer Road, Lancing, West Sussex BN99 8LU.

12. The Form of Proxy must arrive at Aspect House, Spencer Road, Lancing, West Sussex BN99 8LU during usual business hours accompanied by any power of attorney under which it is executed (if applicable) no later than 2:00pm on Wednesday 9 November 2022.

13. The Company may process personal data of attendees and participants at the General Meeting. This may include webcasts, photos, recording and audio and video links, as well as other forms of personal data. The Company shall process such personal data in accordance with its privacy policy.

LOGO

EX-99.4 5 d408355dex994.htm EX-99.4 EX-99.4

Exhibit 99.4

AIM DELISTING

On July 20, 2022 Abcam plc (the “Company” or “Abcam”) announced the Company’s intention to cancel the admission of its Ordinary Shares to trading on AIM (the “AIM Delisting”), subject to shareholder approval.

The announcement can be found at: corporate.abcam.com.

The shareholder circular can be found at: corporate.abcam.com.

As set out in the expected timetable of events below, it is expected that the final day of trading of the Ordinary Shares on AIM will be 13 December 2022 with the AIM Delisting taking effect at 7.00 a.m. on 14 December 2022.

EXPECTED TIMETABLE


Dispatch of this Document and the accompanying documents		17 October 2022

Latest date for receipt of proxy voting instructions and (if applicable) hard copy forms of proxy		2.00 p.m. on 9 November 2022

General Meeting		2.00 p.m. on 11 November 2022

Last date for receipt by the Registrar from certificated shareholders of duly completed Certificated Transfer Forms and original share certificates		5.00 p.m. on 1 December 2022

Latest date for receipt by the Depositary from CREST holders of duly completed issuance forms		5.00 p.m. on 1 December 2022

Expected date for issuance of ADSs to block transfer participants		12 December 2022

Expected date of mailing of ADS confirmations to shareholders by the Depositary		13 December 2022

Last day of dealings in the Ordinary Shares on AIM		13 December 2022

Cancellation of admission to trading on AIM of the Ordinary Shares		7.00 a.m. on 14 December 2022

Notes

(1)	References to time in this Document are to London time unless otherwise stated.

(2)	Each of the times and dates in the above timetable are subject to change. If any of the above times and/or dates change, the revised times and/or dates will be notified to shareholders by announcement through a Regulatory Information Service.

(3)

FREQUENTLY ASKED QUESTIONS

DO I NEED TO SELL MY AIM-QUOTED ORDINARY SHARES OR MUST I DEPOSIT THEM FOR DELIVERY OF NASDAQ-LISTED ADSs?

Holders of Abcam Ordinary Shares now have three options:

You may choose to deposit your Ordinary Shares for delivery of ADSs tradeable on Nasdaq

If your investment is currently held in CREST and managed by a broker, your broker should be able to manage the deposit process for you. Upon shareholder approval, if you wish to deposit your Ordinary Shares for delivery of ADSs, you should contact your broker to initiate this process without delay.

Please see question 6 below “My broker currently holds my Ordinary Shares within a CREST nominee account – how do I deposit my shares for delivery of ADSs?”.

If you hold your investment in certificated form and wish to deposit it for delivery of ADSs without engaging the services of a broker, you may hold ADSs on the books of the Company’s ADS depositary, Citibank, N.A. (“Citi”), in your name in registered uncertificated form. You should complete the certificated transfer form sent to you and return this along with your share certificate in the envelope provided to Equiniti Limited, Aspect House, Spencer Road, Lancing, West Sussex, BN99 6DA.

For details on how to deposit your Ordinary Shares, please see question 3 below “I hold my shares in certificated form and I want to deposit my Ordinary Shares for delivery of ADSs prior to the AIM Delisting but do not want to engage a broker at this time – how do I do this?”..

ii.

You may choose to continue to hold your Ordinary Shares

Ordinary Shares will continue to be a valid equity interest in the Company with full voting rights, rights to future dividends, etc., as currently enjoyed by holders of Ordinary Shares. However, following the AIM Delisting there will be no public market in the United Kingdom on which the Ordinary Shares can be traded. Please see question 8 below “Can I continue to hold Ordinary Shares after the AIM Delisting?”.

iii.

You may choose to sell your AIM-quoted Ordinary Shares prior to the AIM Delisting becoming effective

If you wish to maintain an equity interest in Abcam, you could choose to reinvest in Abcam by using the proceeds of the sale of your Ordinary Shares to buy Nasdaq-listed ADSs (Nasdaq ticker: ABCM). Dealing and tax costs would likely apply to the AIM and/or Nasdaq transactions and you are advised that you will need to appoint a broker in order to affect such a purchase.

I DO NOT HAVE A BROKER – DO I REALLY NEED ONE?

You may wish to engage a broker if you are not participating in the block transfer process described in question 4 below. If you do not already have an account with a broker, you may be able to open one either online or through banks and building societies which offer broking services. You need to ensure that the broker and type of account on offer is capable of holding and trading US-listed securities. Often the most basic account offered is for UK-listed shares

only so you will need to select an account that gives you the ability to buy and sell US-listed securities. Please ensure that you check with your broker that they can hold Abcam ADSs and have a DTC participant account.

I CURRENTLY HOLD MY ORDINARY SHARES IN THE FORM OF A PAPER CERTIFICATE - HOW DOES THE AIM DELISTING AFFECT ME?

Ordinary Shares in certificated form are not currently immediately tradeable as, in order to sell them, the share certificates need to be deposited with a broker and “dematerialised” so that they are held in electronic form in CREST, which is the electronic system for the holding of shares in uncertificated form and paperless settlement of share trades. Only when the Ordinary Shares have been converted into electronic form can they then be traded on AIM.

If you choose to retain your Ordinary Shares in certificated form but do not deposit them for delivery of ADSs prior to the AIM Delisting, in order to sell them following AIM Delisting, you will need to use a broker with UK and US capabilities to firstly dematerialise your UK share certificate into CREST and thereafter to liaise with the Company’s depositary, Citi, to issue the respective ADSs for your broker to sell on your behalf. Your broker will need to contact Citi in order for your Ordinary Shares to be deposited for delivery of ADSs and credited to the account held by your broker. Upon receiving instructions to do so, your broker would then trade your ADSs via Nasdaq and would remit the proceeds to your personal account. Please also see question 8 below “Can I continue to hold Ordinary Shares after the AIM Delisting?”.

Please note that a deposit of Ordinary Shares for delivery of ADSs following the AIM Delisting becoming effective will incur a UK stamp duty, or stamp duty reserve tax (“SDRT”), charge (the rate of which is currently 1.5 per cent. of the market value of the shares deposited), although in all cases professional advice should be sought as to the applicable tax treatment.

I HOLD MY SHARES IN CERTIFICATED FORM AND I WANT TO DEPOSIT MY ORDINARY SHARES FOR DELIVERY OF ADSs PRIOR TO THE AIM DELISTING BUT DO NOT WANT TO ENGAGE A BROKER AT THIS TIME – HOW DO I DO THIS?

If your investment is currently held in certificated form outside of CREST, the Company’s Receiving Agent, Equiniti will facilitate a block transfer process, on behalf of the Company, for those shareholders who do not already hold their Ordinary Shares via a broker and who may wish to participate in a managed deposit process. This process is only available prior to the AIM Delisting to holders of Ordinary Shares in certificated form. Subject to the requisite paperwork being returned to Equiniti by the required deadline, being 5 p.m. on 1 December 2022, Equiniti, will arrange for the relevant Ordinary Shares to be transferred into CREST and then deposit the Ordinary Shares with Citi, who will then arrange for the delivery of ADSs to an account held in the name of the relevant shareholder on the books of the depositary, in registered uncertificated form. Holders of Ordinary Shares in certificated form will be sent a personalised certificated transfer form. If a shareholder wishes to participate in this managed deposit process, they should complete the certificated transfer form and return it to Equiniti in accordance with the instructions set out in the form, so as to be received by Equiniti no later than 5 p.m. on 1 December 2022.

Further certificated transfer forms can be requested from Equiniti at +44 (0) 333 207 5963. Calls are charged at the standard geographic rate and will vary by provider. Calls from outside the UK

will be charged at the applicable international rate. Lines are open 8.30 a.m. to 5.30 p.m., Monday to Friday, excluding public holidays in England and Wales.

Completed certificated transfer forms and original share certificates should be returned to Equiniti at Equiniti Limited, Aspect House, Spencer Road, Lancing, West Sussex, BN99 6DA. UK shareholders can use the pre-paid envelope sent to you. Both UK shareholders and non-UK shareholders may prefer to return certificated transfer forms and original share certificates using registered post.

If the Resolution is not passed at the General Meeting, all documents provided to Equiniti and/or Citi in relation to the deposit of Ordinary Shares for delivery of ADSs shall be of no effect and all original share certificates will be returned to shareholders by Equiniti. Shareholders who hold their Ordinary Shares in certificated form and who do not elect to participate in this block transfer process may utilise the services of a broker to facilitate the deposit.

Following the deposit of Ordinary Shares for delivery of ADSs in registered uncertificated form, note that all registered holders will be subject to US stock transfer procedures and guidelines. Holders should consult with a broker to determine applicable stock transfer requirements in relation to future transfers of ADSs. These requirements may include a medallion signature guarantee to effect certain transfers. Further details on medallion signature guarantees may be found at: www.investor.gov/introduction-investing/investing-basics/glossary/medallion-signature-guarantees-preventing.

I HAVE ALREADY INITIATED THE DEMATERIALISATION OF MY UK SHARE CERTIFICATE INTO CREST IN ORDER TO DEPOSIT MY ORDINARY SHARES FOR DELIVERY OF ADSs – WHAT SHOULD I DO?

In order to participate in the block transfer process being facilitated by Equiniti, you will need to return your original share certificate(s) with your certificated transfer form. Accordingly, if you have already returned your share certificate in order to dematerialize it into CREST, you will not be able to participate in the block transfer process. In these circumstances, you should continue with the dematerialisation process and contact your broker to ensure that this and the delivery of ADSs is completed before the AIM Delisting.

I CURRENTLY HOLD MY ORDINARY SHARES IN UNCERTFICATED/ELECTRONIC FORM IN CREST – HOW DOES THE AIM DELISTING AFFECT ME?

If your investment is currently held in electronic form in CREST and managed by a broker, your broker will be able to manage the deposit process for you.

If your Ordinary Shares are currently held in electronic form in CREST and you do not deposit them for delivery of ADSs before the AIM Delisting, your Ordinary Shares will continue to be held in your CREST account, but in unquoted form. Following the AIM Delisting, you will not be able to publicly trade any of your Ordinary Shares on any listed exchange in CREST as the Company will have cancelled its admission to trading on AIM. Please see question 8 below “Can I continue to hold Ordinary Shares after the AIM Delisting?”. Deposits of Ordinary Shares for delivery of ADSs following the AIM Delisting becoming effective will incur a UK stamp duty, or SDRT, charge (the rate of which is currently 1.5 per cent. of the market value of the shares deposited), although in all cases professional advice should be sought as to the applicable tax treatment.

MY BROKER CURRENTLY HOLDS MY ORDINARY SHARES WITHIN A CREST NOMINEE ACCOUNT – HOW DO I DEPOSIT MY SHARES FOR DELIVERY OF ADSs?

Many UK brokers have the ability to hold and trade Nasdaq-listed securities. In order to continue holding a form of security in the Company that is readily tradeable, you should contact your broker without delay to confirm that Ordinary Shares are deposited for delivery of ADSs. Your broker must provide the Company’s depositary, Citi, with certain details in relation to the deposit (by completing an issuance instruction form) and will then transmit your Ordinary Shares electronically to Citi’s UK custodian’s CREST account.

HOW DOES THE PRICE OF NASDAQ-LISTED ADSs COMPARE TO THE PRICE OF ORDINARY SHARES ON AIM?

Abcam currently maintains a listing of ADSs on the Global Market tier of the Nasdaq Stock Market. Each ADS is a financial instrument that represents one Ordinary Share. The price of each ADS is expressed in US dollars and should approximate the value of the one Ordinary Share that it represents on a currency adjusted basis. Currently, the price of an Ordinary Share on AIM can be compared to the price of Abcam’s Nasdaq-listed ADSs by dividing the ADS price by the US dollar to pounds sterling exchange rate to calculate the approximate equivalent sterling denominated price per Ordinary Share.

As part of the AIM Delisting, holders of Ordinary Shares may deposit such Ordinary Shares for delivery of ADSs (see question 1 “Do I need to sell my AIM-quoted Ordinary Shares or must I deposit them for delivery of Nasdaq listed ADSs?” above). Once Ordinary Shares are deposited and the ADSs subsequently delivered, the investment will be US dollar denominated instead of pounds sterling denominated. This means that when valued in pounds sterling, its value will fluctuate on a day-to-day basis in line with movements in £:US$ exchange rate.

Once the AIM Delisting takes effect on 14 December 2022, there will no longer be a published price for an individual Ordinary Share. It will, however, always be possible to calculate the value of an individual Ordinary Share in pounds sterling by taking the Nasdaq ADS market price and dividing by the US dollar to pounds sterling exchange rate. The Nasdaq ADS price is, and will continue to be, available via Abcam’s website at www.corporate.abcam.com/investors/ or may otherwise be found online on a broad range of financial websites.

CAN I CONTINUE TO HOLD ORDINARY SHARES AFTER THE AIM DELISTING?

Should you wish to do so, it will be possible to continue to hold Ordinary Shares after the AIM Delisting. However, shareholders should be aware that the Ordinary Shares will not be admitted to trading on any public market in the United Kingdom and the Ordinary Shares will not be tradeable on Nasdaq in this form.

Should you wish to sell your Ordinary Shares following the AIM Delisting becoming effective, you will likely be required first to deposit such Ordinary Shares for delivery of ADSs via the Company’s depositary bank, Citi, and any sale of the resulting ADSs will likely need to be via a broker with US share trading capability. Please also see question 2 above “I currently hold my ordinary shares in the form of a paper certificate – how does the AIM delisting affect me?”.

Please note that a deposit of Ordinary Shares for delivery of ADSs following the AIM Delisting becoming effective will incur a UK stamp duty, or SDRT, charge (the rate of

which is currently 1.5 per cent. of the market value of the shares deposited), although in all cases professional advice should be sought as to the applicable tax treatment.

10.

I ALREADY HOLD ADSs – AM I AFFECTED BY THE AIM DELISTING?

The Nasdaq-listed ADSs will continue to trade as normal. Existing holders of ADSs not also holding Ordinary Shares do not need to take any action in connection with the AIM Delisting.

11.

HOW DO I BUY AND SELL NASDAQ LISTED ADSs?

A number of brokers in the UK have the capability to hold US exchange-listed securities and are capable of buying and selling them for you. A small depositary services fee (“DSF”) currently US$0.02 per ADS per annum and an issuance and cancellation fee of US$0.05 per ADS, is levied by the Company’s depositary bank, Citi, pursuant to the terms of the governing deposit agreement, and brokers may also charge an annual fee for holding a US security on your behalf.

Should you wish to increase your holding in the Company, you should be able to purchase further ADSs via your broker. You will need to instruct your broker to purchase Abcam ADSs (Nasdaq ticker: ABCM).

If you wish to continue to hold your investment in the Company directly, without engaging the services of a broker, you may hold ADSs in your name on the books of the Company’s depositary, in registered uncertificated form. If a shareholder wishes to receive ADSs without engaging the services of a broker, please see question 3 above “I hold my Ordinary Shares in certificated form and I want to deposit my Ordinary Shares for delivery of ADSs prior to the AIM Delisting but do not want to engage a broker at this time – how do I do this?”.

12.

IS THERE A COST TO DEPOSIT MY ORDINARY SHARES AND HOLD MY ABCAM INVESTMENT IN THE FORM OF ADSs?

Ordinarily, shareholders who deposit their Ordinary Shares for delivery of ADSs are charged an ADS issuance fee, by the depositary, of up to $0.05 per ADS, pursuant to the terms of the governing deposit agreement. However, no ADS issuance fees will be charged to shareholders who elect to deposit their Ordinary Shares in connection with the AIM Delisting whether on or prior to 14 December 2022 (or such other date being when the AIM Delisting takes effect).

Otherwise than in connection with the AIM Delisting, ADS issuance fees of up to $0.05 per ADS will be charged by the depositary in connection with any future deposits of Ordinary Shares.

The DSF, currently up to US$0.02 per ADS, is levied to ADS holders by Citi annually. This is typically paid and charged to your account by your broker. All ADS holders are required to pay the annual DSF.

13.

HOW WILL THE AIM DELISTING AFFECT THE TAX TREATMENT OF ORDINARY SHARES?

Abcam is not able to provide shareholders with any form of taxation advice and shareholders are strongly advised to seek their own professional advice in order to ascertain the consequences for them of continuing to hold Ordinary Shares following the AIM Delisting becoming effective or depositing Ordinary Shares for delivery of ADSs.

The Company’s understanding of the current position for individuals who are UK resident and UK domiciled under UK taxation law is as follows but it should be noted that the Company has not taken steps to confirm the current position with HMRC. Therefore, the following should not be relied upon by shareholders without taking further advice (and the Company accepts no liability whatsoever in respect of any tax information provided).

The AIM Delisting should not, in itself, alter the classification of the Company’s Ordinary Shares in terms of whether these qualify as unlisted /unquoted securities for the purposes of certain specific UK tax rules (notably, the UK inheritance tax business relief rules), recognising that in October 2020, the Company completed a direct listing of ADSs on Nasdaq. Shareholders should be aware that HMRC has not published any detailed guidance on the treatment of ADSs for inheritance tax purposes to date.

Under HMRC’s stated practice those shareholders who elect to deposit their holdings of Ordinary Shares for delivery of Nasdaq-listed ADSs should not be considered as disposing of the Ordinary Shares for UK capital gains tax purposes when transferring the shares to the Company’s ADS depositary, Citi, in exchange for issue of ADSs on the basis that the shareholder retains beneficial ownership of the Ordinary Shares.

Shareholders who elect to deposit their holdings of Ordinary Shares for delivery of Nasdaq-listed ADSs prior to the AIM Delisting should not incur a stamp duty, or SDRT, charge. It is expected that shareholders who elect to deposit their holdings of Ordinary Shares for delivery of Nasdaq-listed ADSs following the AIM Delisting will incur a stamp duty, or SDRT, charge at the rate of 1.5 per cent. of the market value of the Ordinary Shares being deposited.

It is strongly recommended that shareholders obtain appropriate professional advice in respect of these and other taxes.

14.

WILL THE AIM DELISTING AFFECT MY RIGHTS AS A SHAREHOLDER?

As a company incorporated in England, Abcam will continue to be subject to the requirements of the Companies Act 2006.

Following the AIM Delisting taking effect, the Company will no longer be subject to the AIM Rules for Companies published by London Stock Exchange plc or be required to retain the services of an independent nominated adviser. In addition, the Company will no longer be required to comply with the continuing obligations set out in the Financial Conduct Authority’s Disclosure Guidance and Transparency Rules (“DTRs”) or, provided the Company’s securities remain outside the scope of the regulation, the Market Abuse Regulation (Regulation (EU) No.596/2014) which forms part of domestic law in the United Kingdom pursuant to the European Union (Withdrawal) Act 2018 (as Nasdaq is not an in-scope exchange for the purposes of such legislation). In addition, the Company will no longer be subject to the provisions of the DTRs relating to the disclosure of changes in significant shareholdings in Abcam. The Company intends to continue to comply with all regulatory requirements for the Nasdaq listing of its ADSs, including all applicable rules and regulations of the US Securities and Exchange Commission.

Shareholders who continue to hold Ordinary Shares will continue to be notified in writing of the availability of key documents on our website, including publication of Annual Reports and Annual General Meeting documentation. Holders of ADSs will be able to continue to access all

such information via the Abcam website. Holders of Ordinary Shares and ADSs will both be eligible to receive any future dividends that may be declared.

Following the AIM Delisting taking effect, as the Company will remain a public limited company incorporated in England but its securities will not be admitted to trading on a regulated market or multilateral trading facility in the United Kingdom (or a stock exchange in the Channel Islands or the Isle of Man), the City Code on Takeovers and Mergers (the “City Code”) will only apply to the Company if it is considered by the Panel on Takeovers and Mergers (the “Panel”) to have its place of central management and control in the United Kingdom (or the Channel Islands or the Isle of Man). This is known as the “residency test”. The way in which the test for central management and control is applied for the purposes of the City Code may be different from the way in which it is applied by the United Kingdom tax authorities, HMRC. Under the City Code, the Panel looks to where the majority of the directors of the Company are resident, amongst other factors, for the purposes of determining where the Company has its place of central management and control.

The Panel has confirmed to the Company that following the AIM Delisting, based on the current composition of the Board, the City Code will no longer apply to the Company. However, the City Code could apply to the Company in the future if any changes to the Board composition result in the Panel considering that the Company has its place of central management and control in the United Kingdom (or the Channel Islands or the Isle of Man).

15.

I CURRENTLY HOLD MY ORDINARY SHARES IN AN ISA – CAN I CONTINUE TO DO SO?

Although the AIM Delisting does not directly impact on the ability of a UK shareholder to retain their holding of Ordinary Shares, we understand that some UK ISA operators, particularly those that involve an online share trading account, may insist that the shares held in the ISA must be publicly quoted and may only allow trading in UK companies via low-cost online trading facilities.

Please ask your ISA provider as soon as possible to confirm whether they will allow you to continue to hold your Ordinary Shares or whether they are able to deposit such Ordinary Shares for delivery of Nasdaq-listed ADSs to hold on your behalf. If they do not allow you to continue to hold Ordinary Shares and cannot deposit the Ordinary Shares for delivery of ADSs to hold on your behalf, you should consult an appropriate professional adviser without delay.

16.

I CURRENTLY HOLD MY ORDINARY SHARES IN A SELF-INVESTED PERSONAL PENSION “SIPP” – CAN I CONTINUE TO DO SO?

Although the AIM Delisting does not impact on the ability of a UK shareholder to retain their holding of Ordinary Shares, we understand that some SIPP scheme administrators, particularly those that involve an online share trading account, may insist that the shares held in an individual’s SIPP must be publicly quoted and sometimes only allow trading in UK companies online.

Please ask your SIPP provider as soon as possible to confirm whether they will allow you to continue to hold your Ordinary Shares or whether they are able to deposit your holding of Ordinary Shares for delivery of ADSs and continue to hold such ADSs on your behalf. If they do not allow you to continue to hold Ordinary Shares and cannot deposit the Ordinary Shares for delivery of ADSs on your behalf, you should consult an appropriate professional adviser without delay.

17.

I HAVE LOST MY ORIGINAL ORDINARY SHARE CERTIFICATE – HOW DO I GET ANOTHER ONE IN ORDER TO PROGRESS THE DEPOSIT OF MY ORDINARY SHARES FOR DELIVERY OF ADSs?

If you have lost your share certificate, please contact Equiniti without delay on +44 (0) 333 207 5963. Calls are charged at the standard geographic rate and will vary by provider. Calls outside the United Kingdom will be charged at the applicable international rate. The helpline is open between 08:30 – 17:30, Monday to Friday excluding public holidays in England and Wales.

Equiniti will provide you with a letter of indemnity which should be completed and returned to Equiniti along with the completed transfer form. Please note that there may be a charge for providing a letter of indemnity.

Please note that you will not be able to transfer your certificated shares via Equiniti without either an original share certificate or a completed letter of indemnity being received with your duly completed certificated transfer form before the required deadline, being 5.00 p.m. on 1 December 2022.

18.

I HAVE FURTHER QUESTIONS THAT ARE NOT DEALT WITH SUFFICIENTLY HERE – WHERE CAN I FIND FURTHER INFORMATION?

If you hold your Ordinary Shares via a broker, please discuss with your broker in the first instance.

In respect of any queries regarding completion of the certificated transfer form, a shareholder assistance advice line is being operated by the Company’s Receiving Agent, Equiniti, which can be accessed by all shareholders on +44 (0) 333 207 5963. Calls are charged at the standard geographic rate and will vary by provider. Calls from outside the UK will be charged at the applicable international rate. Lines are open 8.30 a.m. to 5.30 p.m., Monday to Friday, excluding public holidays in England and Wales.

19.

WHAT IF I AM AN “AFFILIATE” UNDER U.S. SECURITIES LAWS (I.E., A DIRECTOR, EXECUTIVE OFFICER OR BENEFICIAL OWNER OF 10% OR MORE OF THE OUTSTANDING EQUITY OF THE COMPANY)?

If you are a director, executive officer or beneficial owner of 10% or more of the outstanding equity of the Company, please contact the Company directly for instructions on how to proceed should you wish to deposit your Ordinary Shares for delivery of ADSs.

GRAPHIC 6 g408355ds1a.jpg GRAPHIC begin 644 g408355ds1a.jpg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end GRAPHIC 7 g408355dsp1c.jpg GRAPHIC begin 644 g408355dsp1c.jpg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end GRAPHIC 8 g408355dsp2a.jpg GRAPHIC begin 644 g408355dsp2a.jpg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end GRAPHIC 9 g408355dsp2b.jpg GRAPHIC begin 644 g408355dsp2b.jpg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end GRAPHIC 10 g408355g00w88.jpg GRAPHIC begin 644 g408355g00w88.jpg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g408355g1013230103027.jpg GRAPHIC begin 644 g408355g1013230103027.jpg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